The drivers most frequently affected by CNVs were GNAS and ASXL1, for which 82% and 81% of nHM tumours had gains and/or amplifications, whereas SMAD4 (79%), SMAD2 (77%) and TP53 (76%) had more deletions and LOH. Here, TP53 is linked to neoplasm.